Here's Why NeoGenomics Rose as Much as 11.2% Today
Shares of NeoGenomics (NASDAQ: NEO) soared over 11% today after the company reported third-quarter 2019 operating results. The genetic testing leader delivered record quarterly revenue of $104.7 million and generated net income of $2.1 million during the period -- nearly as much as the company reported in the first nine months of 2018.
Management also struck an optimistic tone about the company's near- and long-term future. NeoGenomics hired nearly 200 full-time employees and plowed money into research and development (R&D) activities to support growth.
As of 12:22 p.m. EDT, the stock had settled to a 10% gain.
Source Fool.com
